North America Positron Emission Tomography Market

North America Positron Emission Tomography Market Size & Forecast:

• North America Positron Emission Tomography Market Size 2025: USD 1.49 Billion
• North America Positron Emission Tomography Market Size 2033: USD 2.39 Billion
• North America Positron Emission Tomography Market CAGR: 6.09%
• North America Positron Emission Tomography Market Segments: By Type (Digital PET, Analog PET, Hybrid PET/CT, PET/MRI, High-resolution PET, Others); By Application (Oncology, Cardiology, Neurology, Research, Diagnostics, Others); By End-User (Hospitals, Diagnostic Centers, Research Institutes, Clinics, Others); By Component (Scanners, Software, Radiotracers, Detectors, Systems, Others)

To learn more about this report,  Download Free Sample Report

North America Positron Emission Tomography Market Summary:

The North America Positron Emission Tomography Market size is estimated at USD 1.49 Billion in 2025 and is anticipated to reach USD 2.39 Billion by 2033, growing at a CAGR of 6.09% from 2026 to 2033.

Both developed imaging technologies and changing clinical demands contributed towards the healthcare diagnostic market-Positron Emission Tomography in North America. The demand for PET systems will grow among hospitals and research facilities because they require accurate metabolic imaging and efficient clinical decision-making support. The healthcare industry needs to develop better scanning technologies which decrease patient wait times and create more effective imaging procedures that cater to patient needs. 

The combination of detector design advancements and regulatory changes for safer radiopharmaceutical methods will create new clinical usage patterns throughout major regional healthcare networks. The upcoming years will establish standardized imaging procedures across North American healthcare facilities because of these regulatory shifts.

What Has the Impact of Artificial Intelligence Been on the North America Positron Emission Tomography Market?

The North America Positron Emission Tomography Market undergoes rapid transformation because Artificial Intelligence creates new ways for stakeholders to study medical imaging data and forecast demand. The North America Positron Emission Tomography Market shows AI development through North America Positron Emission Tomography Market, which enables better market research results through its ability to process data at higher speeds and extract more in-depth medical information. 

Organizations utilize machine learning models to track changes in demand patterns and enhance their imaging service operations while using predictive analytics to improve their future planning activities. North American Positron Emission Tomography Market artificial intelligence enables better trend forecasting, which allows manufacturers and healthcare providers to adapt their diagnostic approaches to new market conditions.

The North America Positron Emission Tomography Market benefits from smart automation because the technology streamlines imaging processes and decreases human error while it increases the efficiency of scan analysis. The North America Positron Emission Tomography Market shows positive results from AI-driven supply chain optimization, which uses predictive maintenance techniques to decrease equipment downtime and cut operating expenses. 

AI development in the North America Positron Emission Tomography Market leads to new diagnostic imaging technologies that allow healthcare professionals to develop more accurate clinical decision support systems. Healthcare systems experience market growth through artificial intelligence integration because it creates competitive advantages which enable key players to adopt advanced imaging technologies.

Key Market Trends & Insights:

• The north america positron emission tomography market is expanding because there is greater need for testing and precise medical assessments which are required in both cancer treatment and neurological studies. 
• The north american positron emission tomography market has experienced growth because artificial intelligence implementation has increased scanning precision which provides predictive analytics capabilities and streamlines operational processes. 
• The market will achieve its highest value in 2024 because hybrid imaging systems which include PET/CT and PET/MRI will maintain their position as the dominant technology because of their advanced diagnostic performance. 
• North america positron emission tomography market growth depends on two main factors which are rising healthcare spending and reimbursement systems that provide financial support. 
• The growing demand for radiotracers together with new developments in molecular imaging technologies is driving the creation of new clinical applications.

• The United States controls the North American positron emission tomography market because it possesses advanced healthcare systems which enable it to maintain approximately 75% market share during 2024. 
• The market is dominated by PET/CT systems which hold more than 60% market share during 2024 because clinics widely use the systems and the systems provide accurate diagnostic results. 
• The PET/MRI systems represent the quickest expanding market section which will continue to grow until 2030 because of their advanced soft tissue imaging abilities. 
• The oncology field controls approximately 80% of market share during 2024 because of increasing cancer cases and the rising need for early cancer detection methods. 
• The field of neurology develops at its greatest speed because there are increasing cases of Alzheimer’s disease together with other neurological disorders. 
• The main competitors in the market are GE HealthCare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems, and Bracco Imaging.

North America Positron Emission Tomography Market Segmentation

By Type : 

The North America Positron Emission Tomography Market operates through its By Type category which includes six imaging systems that consist of digital PET and analog PET and hybrid PET/CT and PET/MRI and high-resolution PET and additional formats. The different types of medical imaging systems provide various levels of imaging accuracy which healthcare facilities use to meet their clinical requirements. 

Digital PET provides improved sensitivity through its ability to produce images at a higher speed whereas analog PET enables users to perform traditional system setups. The combination of anatomical and functional imaging systems occurs through the use of Hybrid PET/CT and PET/MRI technology. High-resolution PET enables researchers to achieve better detection accuracy whereas other systems provide specialized diagnostic capabilities for research and specialized medical investigations.

By Application : 

The North American Positron Emission Tomography Market segments its applications into six categories which include oncology, cardiology, neurology, research activities, diagnostic procedures and other clinical applications. The demand for functional imaging technology increases because it provides accurate imaging required for both disease detection and treatment planning purposes. 

The field of oncology maintains its position as the leading medical specialty because doctors use it for tumor detection and cancer staging purposes. The field of cardiology uses its technologies to evaluate how well the heart muscle functions. Neurology functions as a tool which helps evaluate brain disorders. Research applications expand imaging studies, while diagnostics improve early disease identification across healthcare systems.

To learn more about this report,  Download Free Sample Report

By End-User : 

The North American Positron Emission Tomography Market divides its end-user segments into hospitals, diagnostic centers, research institutes and clinics and additional healthcare facilities which utilize advanced imaging systems for both clinical use and research activities. 

The hospital sector drives PET equipment adoption because hospitals experience high patient traffic. Diagnostic centers provide imaging services as their main business operation. Research institutes conduct advanced studies with their resources. Clinics use PET for specialized assessments, while other facilities support niche healthcare imaging requirements.

By Component : 

The North American Positron Emission Tomography Market divides its components into five categories which include scanners, software radiotracers detectors and integrated systems that support both imaging workflows and diagnostic accuracy. 

The complete system provides clinical imaging capabilities across healthcare facilities through five essential components which include scanners for data capture software for system analysis and radiotracers that enable metabolic imaging and detectors for enhanced signal reception and systems that connect all components together.

 What are the Main Challenges for the North America Positron Emission Tomography Market Growth?

North America faces multiple technological and operational obstacles which hinder the growth of its positron emission tomography market the most. The north american positron emission tomography market faces its main challenge through the short radioactive scientists work with which determines their time, manufacturing and delivery and usage. The need for advanced technology and specialized machinery makes operational tasks more challenging. The providers face challenges because the system performance prevents them from delivering better image quality and combining their results with other diagnostic tools which restrict their ability to expand operations in the market. 

The north american positron emission tomography market faces multiple restrictions which occur because of operational restrictions that exist between manufacturing processes and their distribution to various business sectors. The production of PET systems and radiopharmaceuticals requires adherence to strict regulatory standards such as Good Manufacturing Practices (GMP), increasing compliance costs and time-to-market. 

The heavy financial burden results from organizations making extensive investments into cyclotrons and radiochemistry laboratories together with their requirements for quality control systems. The business expansion process faces additional obstacles because supply chain problems arise from short-lived isotope transportation which creates distribution challenges and restricts operational territories.

The north america positron emission tomography market faces problems because adoption challenges affect operations of smaller healthcare facilities and rural medical centers. The system cannot be used widely because three factors exist: there is no proper infrastructure and installation costs are excessive and there is a shortage of trained workers. The dual problems of reimbursement uncertainties and funding gaps create obstacles for organizations that seek to adopt new technologies. The market will face long-term threats from two sources: competing imaging methods that include CT and MRI and continuous pricing pressures and changing regulatory standards.

Country Insights

The United States will hold a major share due to advanced healthcare systems and strong imaging infrastructure and high cancer cases. Canada will show steady growth supported by improved hospital facilities and public healthcare support. Regional demand will increase because research activities are expanding and access to nuclear imaging agents is growing. 

The United States will continue to lead demand due to widespread availability of advanced hospitals and imaging centers. PET scan access for patients will increase because strong insurance coverage and reimbursement support will become more widespread. Continuous medical technology investment will enhance diagnostic accuracy and efficiency across all healthcare facilities. 

The healthcare infrastructure improvements in Canadian provinces will lead to gradual growth for the country. The public health services which the government supports together with rising public awareness about early diagnosis will boost the use of imaging. PET technology will become more widely used in clinical studies and disease management through research center and hospital collaboration.

Recent Development News

In April 2026, The company started North American production of its Omni Legend PET/CT system through its newly established manufacturing facility. The company established a production line in Wisconsin and marked its 100th installation across the U.S. and Canada, strengthening regional supply of advanced AI-enabled PET imaging systems. 

Source https://www.gehealthcare.com/

In April 2026, GE HealthCare confirmed continued expansion of PET/CT deployment across North America through new hospital installations. The milestone installation activity reflects rising adoption of digital PET imaging for oncology and precision diagnostics in U.S. healthcare systems.Source https://www.gehealthcare.com/

How Can New Companies Establish a Strong Foothold in the North America Positron Emission Tomography Market?

By concentrating on specific market segments to address important healthcare needs new companies can secure market dominance in the North American positron emission tomography sector. Companies should focus on specific areas which experience increased demand such as oncology imaging and neurology diagnostics and pediatric applications instead of pursuing a broad market approach. 

New market entrants can establish their unique market position by developing products that match existing industry standards in AI-based diagnostic systems and precision healthcare treatments. The North American positron emission tomography market requires companies to develop solutions that tackle essential problems through dedicated research that creates new solutions for restricted radiotracer access and extended scanning durations and excessive operating expenses.

The North American positron emission tomography market requires technology differentiation to create new business development opportunities. Startups that invest in advanced detector technologies, AI-driven image reconstruction and compact or mobile PET systems will achieve better operational results and wider system access. 

For example companies such as RefleXion Medical study biology-guided radiotherapy through PET signals while Subtle Medical uses artificial intelligence to improve imaging results and processing speed. The new companies demonstrate that companies can achieve better market position through their innovation strategies which enable shorter scanning durations and better diagnostic performance and reduced expenses in their specific market area.

The north american positron emission tomography market requires strategic partnerships and collaborations for successful expansion. Hospitals together with diagnostic centers and research institutions should partner with new businesses to test their technologies which will lead to quicker market adoption. 

The company can enhance its operations through partnerships with radiopharmaceutical suppliers and equipment manufacturers because this method helps them solve their distribution and supply chain issues. New companies achieve market growth through the combination of innovative solutions and their selected market entry strategies and effective partnerships.

Key North America Positron Emission Tomography Market Company Insights

The North America Positron Emission Tomography Market demonstrates continuous growth because healthcare systems need more advanced imaging technologies. The North America Positron Emission Tomography Market enables early disease identification which helps doctors make accurate diagnoses for both oncology and neurology patients. The region experiences increased system adoption because hospitals have solid infrastructure while diagnostic requirements continue to rise.

The North America Positron Emission Tomography Market experiences growth through rising cancer and neurological disease cases which require accurate imaging technologies. The need for early medical diagnosis together with better treatment development creates stronger demand for medical imaging services. North America Positron Emission Tomography Market development throughout medical centers receives support from technological advances in imaging systems and improved healthcare facility accessibility.

The North America Positron Emission Tomography Market suffers from two major challenges which include excessive equipment expenses and ongoing maintenance costs. Some areas experience challenging operational conditions because they lack enough qualified personnel to operate their systems. The process of obtaining regulatory approvals together with compliance with safety standards creates delays which hinder system implementation. The North America Positron Emission Tomography Market in particular healthcare environments experiences slow growth because these barriers remain in place despite high market demand.

The North American Positron Emission Tomography Market demonstrates intense competition because international imaging device producers compete by developing new technologies and increasing their system performance. Companies invest in hybrid imaging technologies and improved software solutions to enhance diagnostic precision. The company establishes strategic hospital partnerships and research center collaborations to expand its operational reach and strengthen its position in the North American Positron Emission Tomography Market.

Company List

• Siemens Healthineers
• GE Healthcare
• Philips
• Canon Medical
• Hitachi
• Shimadzu
• Agfa-Gevaert
• Fujifilm
• Bruker
• Mediso
• United Imaging
• Toshiba
• NeuroLogica
• Digirad
• Positron 

What are the Key Use-Cases Driving the Growth of North America Positron Emission Tomography Market?

Oncology is the primary force that drives the North America positron emission tomography market because hospitals use PET imaging for multiple purposes, including initial cancer identification methods and cancer progression determination methods and treatment assessment methods. Through PET/CT scans hospitals and cancer centers can track metabolic tumor development which helps them create more effective treatment strategies. The market experiences significant growth from this application because rising cancer cases throughout North America create a greater need for precise diagnostic methods which can provide results within short time frames.

The north america positron emission tomography market relies on another essential application which doctors use to identify dementia through Alzheimer’s disease and Parkinson’s disease and other cognitive disorder assessments. PET imaging lets doctors observe unusual brain functioning along with protein build-up which lets them see patient conditions at their initial development phase. The expanding application of this technology leads to increased usage at specialized neurological centers and research institutions which drives market development.

The north america positron emission tomography market depends on cardiology because PET scans help physicians evaluate heart muscle health and blood circulation patterns. Physicians use this information to determine patient risk levels and develop treatment strategies for individuals with coronary artery disease. The pharmaceutical industry now uses PET imaging technology to observe real-time drug distribution and effectiveness in drug development and clinical research because of new application methods.

North America Positron Emission Tomography Market Report Segmentation

By Type

• Digital PET
• Analog PET
• Hybrid PET/CT
• PET/MR
• High-resolution PET

By Application

• Oncology
• Cardiology
• Neurology
• Research
• Diagnostics

By End-User

• Hospitals
• Diagnostic Centers
• Research Institutes
• Clinics

By Component

• Scanners
• Software
• Radiotracers
• Detectors
• Systems